Person profile
Address
San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
3
Oruka Therapeutics, Inc.
6 Sep 24
4
Spyre Therapeutics, Inc.
20 Feb 24
4
Spyre Therapeutics, Inc.
2 Feb 24
4
Spyre Therapeutics, Inc.
27 Nov 23
3
Aeglea BioTherapeutics, Inc.
30 Jun 23
4
Eidos Therapeutics, Inc.
28 Jan 21
4
BridgeBio Pharma, Inc.
29 Dec 20
4
Eidos Therapeutics, Inc.
16 Dec 20
4
BridgeBio Pharma, Inc.
25 Nov 20
4
Eidos Therapeutics, Inc.
13 Nov 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 24 | SYRE Spyre Therapeutics | Common Stock | Grant | Acquire A | No | No | 9.82 | 400 | 3.93 k | 746,907 |
1 Feb 24 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.86 | 277,750 | 7.18 mm | 277,750 |
24 Nov 23 | SYRE Spyre Therapeutics | Common Stock | Conversion | Acquire C | No | No | 0 | 723,440 | 0.00 | 746,507 |
24 Nov 23 | SYRE Spyre Therapeutics | Series A Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 18,086 | 0.00 | 0 |
22 Nov 23 | SYRE Spyre Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 10.39 | 374,000 | 3.89 mm | 374,000 |